GTC is proud to present the Biomarker and Diagnostics Conference as part of the Biomarker Summit 2012.

Providing attendees a comprehensive study of using biomarkers as a diagnostic tool, this inaugural Conference focuses on this specific issue without sidetracking into other areas of contemporary research.
Diagnostics is a powerful tool in pharmaceutical development and the battle against disease. Providing attendees with one of the few opportunities to focus exclusively on diagnostics, attendees will benefit by gaining knowledge of today's latest developments by industry experts.
Beyond simply attending a conference, attendees will be part of the larger Biomarker Summit 2012 that also includes:

Biomarker and Diagnostics Conference
6th Biomarker Development Conference
Biomarker Partnering and Deal-Making Conference

Limitless networking opportunities will be provided for attendees across all four Summit tracks. We look forward to welcoming you to the Biomarker Summit 2012!
The Conference features the following sessions:
Plenary Session
Regulatory & Policy Update
Keynote Speaker
4th Oncology Biomarkers Conference
Challenges to Clinical Translation of Oncology Biomarkers
Advancements in Prognostic Markers
Patient Selection and Stratification
Personalized Oncology Care
Emerging Technologies for Oncology Biomarkers
Development of Targeted Oncology Biomarkers